MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 22.40
+0.14 (0.63%)
Sep 26, 2025, 5:35 PM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €741.30 million as of September 26, 2025. Its market cap has increased by 56.35% in one year.
Market Cap
741.30M
Enterprise Value
736.73M
Revenue
27.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
€22.40
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 741.30M, an increase of 407.37%. That is a compound annual growth rate of 26.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 741.30M | 52.60% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | 225.98M | 63.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.29B |
| Sanofi | 95.30B |
| Sartorius Stedim Biotech | 16.69B |
| bioMérieux | 13.34B |
| Eurofins Scientific SE | 10.82B |
| Ipsen | 9.19B |
| ABIVAX Société Anonyme | 5.31B |
| Virbac | 2.63B |